Tumor Profiling in Endometrial Cancer

With our advanced Technologies for Tumor Profiling, Creative Biolabs has developed an unparalleled platform for endometrial tumor profiling. To fulfill every demand of our consumers, our professional scientists are ready to start working on your projects.

Introduction

Endometrial cancer (EC) is a prevalent gynecologic malignancy with high morbidity. A comprehensive endometrial tumor profiling could help explore the heterogeneity and interactions intra-tumor and in the tumor microenvironment (TME) of EC, as shown in Fig.1. Thus, endometrial tumor profiling is urgently needed for novel biomarker identification, prognostic and diagnostic analysis, and personalized immunotherapy.

The heterogeneity overview of human endometrial cancer.Fig.1 Overview of human endometrial cancer heterogeneity. (Yu; et al, 2022)

Tumor Profiling in Endometrial Cancer at Creative Biolabs

Recent technological advances in tumor profiling area have provided us insight into the endometrial cancer heterogeneity. With industry-leading expertise and state-of-the-art single-use equipment, Creative Biolabs has pioneered endometrial tumor profiling.

Tumor Profiling in Endometrial Cancer

Tumor profiling with tumor biomarkers could help support prognosis and precise treatment development, leading to future research improvement of brain cancer.

Tumor Profiling in Endometrial Cancer

Tumor Profiling in Endometrial Cancer

Tumor Profiling in Endometrial Cancer

Features of Tumor Profiling in Endometrial Cancer at Creative Biolabs

Creative Biolabs is pleased to present world-leading tumor Profiling. For more details, please feel free to contact us directly.

Reference

  1. Yu, Z.; et al. Single-cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer. Cell Proliferation. 2022, 55(6): e13249.

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2024 Creative Biolabs. All Rights Reserved.